We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Many IBS Patients Suffer from Vitamin D Deficiency

By HospiMedica International staff writers
Posted on 04 Jan 2016
The irritable bowel syndrome (IBS) population exhibits significant levels of vitamin D insufficiency and would benefit from screening, suggests a new pilot study.

Researchers at the University of Sheffield (United Kingdom) and Cultech (Port Talbot, United Kingdom) conducted a randomized, double blinded, three-arm parallel design study of vitamin D, placebo, or a combination of vitamin D and probiotics in 51 IBS patients. Study participants were further stratified according to whether they were vitamin D replete or insufficient, as determined by a blood test at baseline and exit. IBS symptoms were assessed by validated questionnaire, and dietary intakes were assessed by food frequency questionnaire.

The results showed that 82% of the IBS cohort in the study was vitamin D deficient, to such a degree that repletion levels could not be adequately recruited. The researchers also found a significant association in the baseline data between circulating vitamin D level and quality of life. Subsequent Vitamin D supplementation succeeded in significantly improving vitamin D level, although the IBS symptoms themselves were not significantly improved during the pilot study. The study was published on December 21, 2015, in BMJ Open Gastroenterology.

“IBS is a poorly understood condition which impacts severely on the quality of life of sufferers. Our work has shown that most IBS sufferers in our trial had insufficient levels of vitamin D,” said lead author Bernard Corfe, PhD, of the University of Sheffield molecular gastroenterology research group. “Furthermore there was an association between vitamin D status and the sufferer's perceived quality of life, measured by the extent to which they reported impact on IBS on life.”

IBS is a diagnosis of exclusion. It is a functional bowel disorder characterized by chronic abdominal pain, discomfort, bloating, and alteration of bowel habits in the absence of any detectable organic cause. In some cases, the symptoms are relieved by bowel movements. Diarrhea or constipation may predominate, or they may alternate (classified as IBS-D, IBS-C or IBS-A, respectively). IBS may begin after an infection (post-infectious, IBS-PI), a stressful life event, or onset of maturity without any other medical indicators.

Related Links:

University of Sheffield
Cultech



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Multilevel Self-Loading Stretcher
CARRERA XL

Latest Critical Care News

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs

On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants